Moderna, Inc. (MRNA)
| Previous close | 148.18 |
| Open | 149.92 |
| Bid | 152.61 x 800 |
| Ask | 152.76 x 800 |
| Day's range | 150.26 - 153.76 |
| 52-week range | 115.03 - 217.25 |
| Volume | |
| Avg. volume | 3,806,430 |
| Market cap | 58.627B |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | 7.45 |
| EPS (TTM) | 20.40 |
| Earnings date | 02 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 226.64 |
- Yahoo Finance Video
Moderna defends COVID-19 vaccine price hike before U.S. Senate
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss Moderna CEO Stephane Bancel’s testimony before the U.S. Senate health committee.
- GlobeNewswire
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Collaboration will extend the applications of each company’s platform through discovery and development of novel lipid nanoparticles using Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system Moderna has acquired an option to license Generation Bio’s ctLNP and closed-ended DNA (ceDNA) technology for two immune cell programs and two liver programs, with an additional option for a third immune cell or liver program Moderna will fund all research and develop
- Motley Fool
It Will Cost More Than $100 to Get a Moderna Covid Vaccine
Remember when they used to be free? As the US government winds down its pandemic emergency spending, health giant Moderna is preparing to shift its...
